BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 760658)

  • 1. Systemic lupus erythematosus: association with psoralen--ultraviolet-A treatment of psoriasis.
    Eyanson S; Greist MC; Brandt KD; Skinner B
    Arch Dermatol; 1979 Jan; 115(1):54-6. PubMed ID: 760658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
    Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
    Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of ultraviolet light in the pathogenesis of systemic lupus erythematosus: case report and discussion of the literature].
    Pirner K; Rubbert A; Salinger R; Kalden JR; Manger B
    Z Rheumatol; 1992; 51(1):20-4. PubMed ID: 1574932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of methotrexate and betamethasone with experimental phototoxic inflammation to PUVA (Psoralen and UVA) in mice.
    Ljunggren B; Möller H
    Arch Dermatol Res; 1979 Mar; 264(2):257-60. PubMed ID: 464643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair synthesis in human skin exposed to ultraviolet radiation used in PUVA (psoralen and UV-A) therapy for psoriasis.
    Bishop SC
    Br J Dermatol; 1979 Oct; 101(4):399-405. PubMed ID: 508605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin.
    Olafsson S; Rodriguez E; Lawson ARJ; Abascal F; Huber AR; Suembuel M; Jones PH; Gerdes S; Martincorena I; Weidinger S; Campbell PJ; Anderson CA
    Nat Genet; 2023 Nov; 55(11):1892-1900. PubMed ID: 37884686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature.
    Dowdy MJ; Nigra TP; Barth WF
    Arthritis Rheum; 1989 Mar; 32(3):343-6. PubMed ID: 2649111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous carcinoma following psoralen and long-wave ultraviolet radiation (PUVA) therapy for psoriasis.
    Brown FS; Burnett JW; Robinson HM
    J Am Acad Dermatol; 1980 May; 2(5):393-5. PubMed ID: 6892920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PUVA treatment of psoriasis.
    Whitefield M; Hudson HR; Hyatt D
    Br Med J; 1978 May; 1(6124):1418-9. PubMed ID: 647315
    [No Abstract]   [Full Text] [Related]  

  • 11. An evaluation of the preferences of patients with psoriasis between systemic psoralen plus ultraviolet A and bath psoralen plus ultraviolet A.
    Alshiyab D; Chin MF; Edwards C; Anstey AV
    Br J Dermatol; 2015; 172(5):1457-8. PubMed ID: 25420468
    [No Abstract]   [Full Text] [Related]  

  • 12. [Puvatherapy and systemic lupus erythematosus].
    Bianchi CA; Milicich R; Stringa O; Schiuma A
    Med Cutan Ibero Lat Am; 1983; 11(5):303-6. PubMed ID: 6366386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Testing the monooxygenase enzyme system of the liver using the antipyrine test in psoriasis patients].
    Akovbian VA; Krakovskiĭ ME; Ashirmetov AKh
    Vestn Dermatol Venerol; 1986; (9):38-41. PubMed ID: 3799048
    [No Abstract]   [Full Text] [Related]  

  • 14. [Photochemotherapy with psoralen and long-wave ultraviolet light. 1 1/2 year of experience of 2 dermatologic department in Tromsø].
    Kavli G
    Tidsskr Nor Laegeforen; 1978 Feb; 98(5):269-70. PubMed ID: 628923
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandins in PUVA-treated psoriasis.
    Heiligstädt H; Kassis B; Weismann K; Søndergaad J
    Acta Derm Venereol; 1978; 58(3):213-6. PubMed ID: 78634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psoralen/UVA treatment and chromosomes. II. Analyses of psoriasis patients.
    Brøgger A; Waksvik H; Thune P
    Arch Dermatol Res; 1978 May; 261(3):287-94. PubMed ID: 686812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resolution of psoriatic lesions in erythematous skin induced by PUVA treatment.
    Vukas A; Batistić B; Zambal Z
    Acta Med Iugosl; 1979; 33(2):147-53. PubMed ID: 506793
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and histological evaluation of oral psoralen plus UV-A exposure (PUVA) for treating psoriasis vulgaris (author's transl)].
    Jimbow K; Nishio C; Uesugi T; Katoh M; Kato M; Makita A; Chiba M; Horikoshi T
    Nihon Hifuka Gakkai Zasshi; 1978; 88(1):23-36. PubMed ID: 306462
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of the eyes against damage by light activated psoralen.
    Peek R; Swarbrick P; Stevenson R; Paver K
    Med J Aust; 1979 Feb; 1(4):113-4. PubMed ID: 431454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid. Occurrence in psoriasis treated with psoralens plus long-wave ultraviolet radiation.
    Abel EA; Bennett A
    Arch Dermatol; 1979 Aug; 115(8):988-9. PubMed ID: 380470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.